Context
The level of evidence is low for the treatment of patients with dysthyroid optic neuropathy (DON) and there is no consensus on the treatment of DON with intravenous high-dose glucocorticoids (ivGC) or direct surgical decompression.
Objective
To compare the efficacy of glucocorticoid treatment and orbital decompression (OD) in DON.
Data Sources
PubMed, EMBASE, and Cochrane Library were searched along with other sources.
Study Selection
A total of 17 studies met the inclusion criteria.
Data Extraction
Standard methodological guidance of the Cochrane Handbook was used and data were independently extracted by multiple observers. The primary outcomes were the improvement of best corrected visual acuity (ΔBCVA). Secondary outcomes were proptosis reduction, change in diplopia, visual field defects, and intraocular pressure (IOP).
Data Synthesis
The ΔBCVA in the ivGC + OD group was improved 0.26 LogMAR more than in the ivGC group (p = 0.007). The ΔBCVA in the OD group was better than in the ivGC group (p = 0.008). Post-treatment proptosis in the ivGC + OD and OD groups were improved further by 3.54 mm and 3.00 mm, respectively, than in the ivGC group (p < 0.01). The mean deviation (MD) in the ivGC + OD group was improved by an additional 5.33 dB than in the ivGC group (p = 0.002). The IOP in the ivGC + OD group was improved further than in the ivGC group (p = 0.03).
Conclusions
Based on the results of the present meta-analysis, OD or ivGC + OD may be more effective in improving BCVA and MD and reducing proptosis compared with ivGC. Compared with ivGC alone, ivGC + OD is more effective in improving IOP than ivGC. Although this study improves the hierarchy of evidence in the treatment of DON, additional RCTs are needed to confirm this conclusion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.